75 related articles for article (PubMed ID: 19731326)
1. Local cytokine therapy of cancer: interleukin-2, interferons and related cytokines.
BubenÃk J; Den Otter W; Huland E
Cancer Immunol Immunother; 2000 May; 49(2):116-22. PubMed ID: 10823422
[TBL] [Abstract][Full Text] [Related]
2. Single-institution outcome of high-dose interleukin-2 (HD IL-2) therapy for metastatic melanoma and analysis of favorable response in brain metastases.
Powell S; Dudek AZ
Anticancer Res; 2009 Oct; 29(10):4189-93. PubMed ID: 19846971
[TBL] [Abstract][Full Text] [Related]
3. What can we learn from phase II adjuvant trials in melanoma?
Keilholz U; Suciu S; Eggermont AM
Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
[No Abstract] [Full Text] [Related]
4. Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients.
Ridolfi L; Fiorentini G; Guida M; Michiara M; Freschi A; Aitini E; Ballardini M; Bichisao E; Ridolfi R;
Melanoma Res; 2009 Apr; 19(2):100-5. PubMed ID: 19262411
[TBL] [Abstract][Full Text] [Related]
5. Mucosal melanoma.
Seigler HF
J Surg Oncol; 2004 Jul; 86(4):187-8. PubMed ID: 15221925
[No Abstract] [Full Text] [Related]
6. Administration of high-dose interleukin-2 in a 2-year-old with metastatic melanoma.
Bernhardt MB; Hicks MJ; Pappo AS
Pediatr Blood Cancer; 2009 Dec; 53(7):1346-8. PubMed ID: 19731326
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous head and neck melanoma: the old and the new.
Rigual NR; Popat SR; Jayaprakash V; Jaggernauth W; Wong M
Expert Rev Anticancer Ther; 2008 Mar; 8(3):403-12. PubMed ID: 18366288
[TBL] [Abstract][Full Text] [Related]
8. The treatment of malignant melanoma.
Rosin RD
Eur J Surg Oncol; 1985 Jun; 11(2):111-5. PubMed ID: 3891412
[No Abstract] [Full Text] [Related]
9. Rapid growth of malignant melanoma in pregnancy.
Sato T; Ishiko A; Saito M; Tanaka M; Ishimoto H; Amagai M
J Dtsch Dermatol Ges; 2008 Feb; 6(2):126-9. PubMed ID: 18042251
[TBL] [Abstract][Full Text] [Related]
10. New therapies for malignant melanoma.
Hancock B
Practitioner; 1989 Oct; 233(1477):1385-6, 1388. PubMed ID: 2482487
[TBL] [Abstract][Full Text] [Related]
11. Locoregional therapies in melanoma.
Abbott AM; Zager JS
Surg Clin North Am; 2014 Oct; 94(5):1003-15, viii. PubMed ID: 25245964
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
